Devices › Device types
FDA product code MNB · class 3 · Unknown
Device, thermal ablation, endometrial: medical device reports filed with FDA
6,321 reports carry this product code, 1997–2026; 10 brands with a page.
- 6,321
- reports with this product code
- 0% of all MAUDE reports
- 176
- reports, 12 months to August 2026
- 256 in the 12 months before
- 30.8%
- classified as malfunction
- 62.3% across all reports
- 0.3%
- classified as death, as reported
- 0.9% across all reports
Product code MNB is FDA's classification for "Device, thermal ablation, endometrial" (unknown panel), a class 3 device. 6,321 medical device reports carry this product code, 0% of the MAUDE database, from December 1997 to August 2026.
176 reports arrived in the 12 months to August 2026, down 31% from 256 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (66.7%), malfunction (30.8%) and other (1.4%). 10 brand names with a page on this site carry this code; the brands table is ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Brands with this product code
| Brand | Reports | Latest 12 months | Classified as death | Classified as malfunction |
|---|---|---|---|---|
| Novasure Impedance Controlled Ea System | 1,941 | 0 | 0.4% | 3.1% |
| Novasure | 1,031 | 140 | 0.4% | 54.8% |
| Genesys Hta Procerva | 400 | 0 | 0% | 34.3% |
| Hydro Thermablator Hta Endometrial Ablation System | 370 | 0 | 0% | 51.1% |
| Novasure Suresound | 193 | 7 | 0% | 30.1% |
| Hydrothermablator Procedure Set | 182 | 0 | 0% | 19.2% |
| Hyrdothermablator Procedure Set | 154 | 0 | 0% | 12.3% |
| Thermachoice | 148 | 0 | 1.1% | 50.9% |
| Myosure Hysteroscopic Tissue Removal System | 1 | 0 | 1.4% | 15.3% |
| Resolution Clip Device | 1 | 0 | 0.3% | 90.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Manufacturers named
| Manufacturer (as written on reports) | Reports | Share |
|---|---|---|
| Hologic | 3,163 | 50% |
| Boston Scientific - Marlborough | 699 | 11.1% |
| Boston Scientific | 326 | 5.2% |
| Boston Scientific - Spencer | 101 | 1.6% |
| Ethicon | 56 | 0.9% |
| Boston Scientific - Fremont Ce | 49 | 0.8% |
| Coopersurgical | 27 | 0.4% |
| American Medical Systems | 1 | 0% |
| Atricure | 1 | 0% |
Reports by month, five years
FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
Event type and report source
Event type
Who filed
Grey bar: all 26,136,888 MAUDE reports.
Device problems coded
| Device problem (FDA code) | Reports | Share |
|---|---|---|
| Insufficient device problem information | 457 | 7.2% |
| Fluid/blood leak | 447 | 7.1% |
| Leak/splashthe device leaked | 277 | 4.4% |
| Device handling problem | 274 | 4.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 240 | 3.8% |
| Material puncture/hole | 223 | 3.5% |
| Device displays incorrect message | 180 | 2.8% |
| Other (for use when an appropriate device code cannot be identified) | 124 | 2% |
| Replace | 104 | 1.6% |
| Balloon leak(s) | 97 | 1.5% |
| Device issuea problem with the device | 77 | 1.2% |
| Loss of powerthe device lost power | 74 | 1.2% |
| Material deformation | 61 | 1% |
| Device inoperablethe device could not be used | 56 | 0.9% |
| Alarm, audible | 53 | 0.8% |
| Detachment of device or device componentpart of the device came off | 52 | 0.8% |
| Breakthe device broke | 50 | 0.8% |
| Device alarm system | 47 | 0.7% |
| Decrease in pressure | 46 | 0.7% |
| Overheating of device | 43 | 0.7% |
Questions about device, thermal ablation, endometrial reports
What is product code MNB?
FDA's classification code for "Device, thermal ablation, endometrial", class 3, reviewed by the unknown panel. Every device report carries the product code of the device involved.
How many reports carry this code?
6,321 reports through August 2026, 176 of them in the latest 12 months.
Which brands appear most often?
Novasure Impedance Controlled Ea System (1,941), Novasure (1,031), Genesys Hta Procerva (400), Hydro Thermablator Hta Endometrial Ablation System (370) and Novasure Suresound (193). Widely used products collect more reports because more people use them.
Can the brands table be used to rank the devices?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." Brands differ in how many are in use, how long they have been sold and how reports are collected.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.